INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. MSFT

Go back to INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
(NASDAQ: INMB) Delayed: 1.37 -0.08 (5.52%)
Previous Close $1.45    52 Week High $ 
Open $1.41    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.35    EPS $ 
Volume 160,226